Subunit RSV vaccine has potentialInpharma Weekly -doi:10.2165/00128413-199409650-00024NoneSpringer International PublishingInpharma Weekly
Get the influenza (flu) vaccine as soon as recommended each year, usually starting in September or October. Get the pneumonia and respiratory syncytial virus (RSV) vaccines, if recommended. Your healthcare provider can tell you if you also need other vaccines, and when to get them. Where can...
During a session at the Outcomes 2024 SYNC National Conference, Pacience Edwards, PharmD, manager of compliance at Outcomes, discussed the impacts that advancements in technology have had on pharmacy. The pharmacy landscape has changed significantly over the past couple of decades, due in large par...
Protocol This trial protocol has been provided by the authors to give readers additional information about their work. Protocol for: Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020;383:2603-15. DOI: 10.1056/NEJMoa...
During the interview, Dokoupil said that "this will not be a regular vaccine because the technologies being used have never been approved so far for a vaccine. And in addition, this is a sped-up process." When asked about the November 1 date in the CDC's letter to state governors, Azar...
This article has been updatedAbstract RSV infection is typically associated with secondary bacterial infection. We hypothesise that the local airway immune response to RSV has incidental antibacterial effects. Using coordinated proteomics and metagenomics analysis we simultaneously analysed the microbiota and ...
“We’re conducting clinical trials with this vaccine in support of a potential regulatory submission and expect to have the first data from these trials in April,” she said. Until an Omicron-adapted vaccine is both approved and available, BioNTech said a further booster shot could be ...
far more on the private market, although in a statement to KHN, Pfizer declined to share the planned price. The government will alsostop paying for the company's COVID vaccinenext year — those shots willquadruple in price, from the discount rate the government pays of $30 to about $120...
Moderna has begun testing itsCOVID-19vaccine on young children, thecompany announcedTuesday. The study, calledKidCOVE, is testing Moderna's vaccine candidate in children ages 6 months to less than 12 years old. "It is humbling to know that 53 million doses have been administered to people ...